James C. Wernz

Protective Effect of the Bispiperazinedione ICRF-187 against Doxorubicin-Induced Cardiac Toxicity in Women with Advanced Breast Cancer

James L. Speyer, Michael D. Green, E Douglas Kramer et al. · New England Journal of Medicine · 1988 · 355 citations

Kaposi's Sarcoma in the Acquired Immune Deficiency Syndrome: A Proposal for Uniform Evaluation, Response, and Staging Criteria

Susan E. Krown, Craig E. Metroka, James C. Wernz · 1989 · 217 citations

Primary Immunodeficiency, Autoimmune Disease, Immunodeficiencies +8

Carcinomatous meningitis from transitional cell carcinoma of bladder

Sue Mandell, James C. Wernz, Pablo Morales et al. · Urology · 1985 · 30 citations

Urology, Carcinomatous Meningitis, Genitourinary Cancer +4

Phase I clinical trial of 9,10-anthracene dicarboxaldehyde (Bisantrene) administered in a five-day schedule.

Robert J. Spiegel, Ronald H. Blum, Mark Levin et al. · PubMed · 1982 · 26 citations

9,10-Anthracene Dicarboxaldehyde, Medicinal Chemistry, Daily I.v +12

Advanced ovarian cancer: Three-year results of a 6–8 month, 2-drug cisplatin-containing regimen

M. Piccart, James L. Speyer, James C. Wernz et al. · European Journal of Cancer and Clinical Oncology · 1987 · 22 citations

Advanced Ovarian Cancer, Medicine, Metronomic Therapy +8